Patent directory · USPTO A61K / A61P
Patents matching “CELGENE CORP [CH]”
8 pharma patents match "CELGENE CORP [CH]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 8 pharmaceutical patents matching "CELGENE CORP [CH]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
AU 2012362562
Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetyl aminoisoindoline-1,3-dione
granted -
AU 2012308663
Formulations of cyclopropanecarboxylic acid {2-[1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amidecelgene corporation state of incorporation:delaware
granted -
AU 2012249536
Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
granted -
AU 2013203283
Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyophenyl)-2-methanesulfonylethylamine
granted -
AU 2012205809
Phenethylsulfone isoindoline derivatives as inhibitors of PDE 4 and/or cytokines
granted -
AU 2008353468
Solid forms comprising (+)-2- [1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl] -4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
granted -
AU 2005269367
Isoindoline compounds and methods of their use
expired -
AU 2003224729
(+)-2-(1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL)-4-ACETYLAMINOISOINDOLINE-1,3-DIONE: METHODS OF USING AND COMPOSITIONS THEREOF
expired